ArticleSurgery today2020

Facilitated completion of 1-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer by medical oncologists.

Yosuke Kano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.